Cargando…

A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide

Long‐acting somatostatin analogs, including lanreotide slow release (LAN‐SR) and octreotide long‐acting release (OCT‐LAR), can improve hypoglycemia in insulinoma. LAN‐SR may be more beneficial in some patients with insulinoma than OCT‐LAR.

Detalles Bibliográficos
Autores principales: Yamaoka, Keiko, Nagashima, Shuichi, Okada, Nobukazu, Sawayama, Nagisa, Saito, Shinsuke, Takahashi, Manabu, Okada, Kenta, Endo, Kazuhiro, Koizumi, Masaru, Sasanuma, Hideki, Ebihara, Ken, Kasajima, Atsuko, Fukushima, Noriyoshi, Sata, Naohiro, Ishibashi, Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133073/
https://www.ncbi.nlm.nih.gov/pubmed/34026158
http://dx.doi.org/10.1002/ccr3.4118
_version_ 1783695013871353856
author Yamaoka, Keiko
Nagashima, Shuichi
Okada, Nobukazu
Sawayama, Nagisa
Saito, Shinsuke
Takahashi, Manabu
Okada, Kenta
Endo, Kazuhiro
Koizumi, Masaru
Sasanuma, Hideki
Ebihara, Ken
Kasajima, Atsuko
Fukushima, Noriyoshi
Sata, Naohiro
Ishibashi, Shun
author_facet Yamaoka, Keiko
Nagashima, Shuichi
Okada, Nobukazu
Sawayama, Nagisa
Saito, Shinsuke
Takahashi, Manabu
Okada, Kenta
Endo, Kazuhiro
Koizumi, Masaru
Sasanuma, Hideki
Ebihara, Ken
Kasajima, Atsuko
Fukushima, Noriyoshi
Sata, Naohiro
Ishibashi, Shun
author_sort Yamaoka, Keiko
collection PubMed
description Long‐acting somatostatin analogs, including lanreotide slow release (LAN‐SR) and octreotide long‐acting release (OCT‐LAR), can improve hypoglycemia in insulinoma. LAN‐SR may be more beneficial in some patients with insulinoma than OCT‐LAR.
format Online
Article
Text
id pubmed-8133073
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81330732021-05-21 A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide Yamaoka, Keiko Nagashima, Shuichi Okada, Nobukazu Sawayama, Nagisa Saito, Shinsuke Takahashi, Manabu Okada, Kenta Endo, Kazuhiro Koizumi, Masaru Sasanuma, Hideki Ebihara, Ken Kasajima, Atsuko Fukushima, Noriyoshi Sata, Naohiro Ishibashi, Shun Clin Case Rep Case Reports Long‐acting somatostatin analogs, including lanreotide slow release (LAN‐SR) and octreotide long‐acting release (OCT‐LAR), can improve hypoglycemia in insulinoma. LAN‐SR may be more beneficial in some patients with insulinoma than OCT‐LAR. John Wiley and Sons Inc. 2021-05-19 /pmc/articles/PMC8133073/ /pubmed/34026158 http://dx.doi.org/10.1002/ccr3.4118 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Yamaoka, Keiko
Nagashima, Shuichi
Okada, Nobukazu
Sawayama, Nagisa
Saito, Shinsuke
Takahashi, Manabu
Okada, Kenta
Endo, Kazuhiro
Koizumi, Masaru
Sasanuma, Hideki
Ebihara, Ken
Kasajima, Atsuko
Fukushima, Noriyoshi
Sata, Naohiro
Ishibashi, Shun
A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide
title A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide
title_full A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide
title_fullStr A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide
title_full_unstemmed A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide
title_short A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide
title_sort case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133073/
https://www.ncbi.nlm.nih.gov/pubmed/34026158
http://dx.doi.org/10.1002/ccr3.4118
work_keys_str_mv AT yamaokakeiko acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT nagashimashuichi acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT okadanobukazu acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT sawayamanagisa acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT saitoshinsuke acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT takahashimanabu acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT okadakenta acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT endokazuhiro acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT koizumimasaru acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT sasanumahideki acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT ebiharaken acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT kasajimaatsuko acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT fukushimanoriyoshi acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT satanaohiro acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT ishibashishun acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT yamaokakeiko caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT nagashimashuichi caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT okadanobukazu caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT sawayamanagisa caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT saitoshinsuke caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT takahashimanabu caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT okadakenta caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT endokazuhiro caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT koizumimasaru caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT sasanumahideki caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT ebiharaken caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT kasajimaatsuko caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT fukushimanoriyoshi caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT satanaohiro caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide
AT ishibashishun caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide